首页 > 最新文献

Contemporary Clinical Trials Communications最新文献

英文 中文
Protocol for a randomized controlled trial of the Mommy&Me study: A multi-modal approach to address social determinants of health and mental health among low-income Black perinatal populations 妈妈和我研究的随机对照试验方案:解决低收入黑人围产期人群健康和心理健康的社会决定因素的多模式方法
IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-04-21 DOI: 10.1016/j.conctc.2025.101489
Huynh-Nhu Le , Nickie Andescavage , Jennifer M. Keller , Maariya M. Bassa , Aimee L. Danielson , Diedtra Henderson , Shanae Bond , Nandi Mjenga , Stephanie Wells , Patricia Quinn , Catherine Limperopoulos

Background

Mental health disorders, including stress, anxiety, and depression, are the most common complications during pregnancy, with significant racial disparities in prevalence and access to care. Low-income Black/African American/of African descent (Black) individuals are at greater risk for perinatal mental health issues and face more obstacles to care due to a variety of barriers, including poor implementation of screening protocols, stigma, adverse experiences of social determinants of health, and distrust of healthcare systems. These disparities are particularly striking in Washington, DC, and worsened during the COVID-19 pandemic.

Methods

This study has two aims: (1) to refine an individualized plan to integrate patient navigation and a culturally adapted cognitive-behavioral (CBT) prevention and treatment intervention for low-income Black pregnant women; and (2) to determine the effectiveness of multiple interventions: patient navigation, culturally adapted CBT, and/or peer support groups versus usual care for pregnant individuals at subthreshold and threshold risk for prenatal stress, depression and/or anxiety in a two-arm prospective longitudinal randomized controlled study. Outcomes will be tracked from pregnancy through 12 months postpartum, assessing maternal mental health, engagement with the intervention, healthcare experiences and utilization, and infant outcomes.

Conclusions

If found to be efficacious, results will help develop scalable, culturally relevant interventions aimed at reducing racial disparities in maternal mental health care and improving health outcomes for both mothers and infants. Trial registration: ClinicalTrials.gov ID NCT05345834.
心理健康障碍,包括压力、焦虑和抑郁,是怀孕期间最常见的并发症,在患病率和获得护理方面存在显著的种族差异。低收入黑人/非裔美国人/非洲人后裔(黑人)个体面临围产期心理健康问题的更大风险,由于各种障碍,包括筛查方案执行不当,污名化,健康社会决定因素的不良经历以及对医疗保健系统的不信任,他们面临更多的护理障碍。这些差异在华盛顿特区尤为明显,在2019冠状病毒病大流行期间进一步恶化。方法本研究有两个目的:(1)为低收入黑人孕妇制定个性化的患者导航和文化适应性认知行为(CBT)预防和治疗干预方案;(2)确定多种干预措施的有效性:在一项两组前瞻性纵向随机对照研究中,患者导航、文化适应性CBT和/或同伴支持团体与产前压力、抑郁和/或焦虑的阈下和阈下风险孕妇个体的常规护理。结果将被跟踪从怀孕到产后12个月,评估产妇的心理健康,参与干预,医疗保健经验和利用,以及婴儿的结果。结论:如果发现有效,结果将有助于开发可扩展的、与文化相关的干预措施,旨在减少孕产妇心理保健中的种族差异,改善母婴的健康结果。试验注册:ClinicalTrials.gov ID NCT05345834。
{"title":"Protocol for a randomized controlled trial of the Mommy&Me study: A multi-modal approach to address social determinants of health and mental health among low-income Black perinatal populations","authors":"Huynh-Nhu Le ,&nbsp;Nickie Andescavage ,&nbsp;Jennifer M. Keller ,&nbsp;Maariya M. Bassa ,&nbsp;Aimee L. Danielson ,&nbsp;Diedtra Henderson ,&nbsp;Shanae Bond ,&nbsp;Nandi Mjenga ,&nbsp;Stephanie Wells ,&nbsp;Patricia Quinn ,&nbsp;Catherine Limperopoulos","doi":"10.1016/j.conctc.2025.101489","DOIUrl":"10.1016/j.conctc.2025.101489","url":null,"abstract":"<div><h3>Background</h3><div>Mental health disorders, including stress, anxiety, and depression, are the most common complications during pregnancy, with significant racial disparities in prevalence and access to care. Low-income Black/African American/of African descent (Black) individuals are at greater risk for perinatal mental health issues and face more obstacles to care due to a variety of barriers, including poor implementation of screening protocols, stigma, adverse experiences of social determinants of health, and distrust of healthcare systems. These disparities are particularly striking in Washington, DC, and worsened during the COVID-19 pandemic.</div></div><div><h3>Methods</h3><div>This study has two aims: (1) to refine an individualized plan to integrate patient navigation and a culturally adapted cognitive-behavioral (CBT) prevention and treatment intervention for low-income Black pregnant women; and (2) to determine the effectiveness of multiple interventions: patient navigation, culturally adapted CBT, and/or peer support groups versus usual care for pregnant individuals at subthreshold and threshold risk for prenatal stress, depression and/or anxiety in a two-arm prospective longitudinal randomized controlled study. Outcomes will be tracked from pregnancy through 12 months postpartum, assessing maternal mental health, engagement with the intervention, healthcare experiences and utilization, and infant outcomes.</div></div><div><h3>Conclusions</h3><div>If found to be efficacious, results will help develop scalable, culturally relevant interventions aimed at reducing racial disparities in maternal mental health care and improving health outcomes for both mothers and infants. Trial registration: <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> ID NCT05345834.</div></div>","PeriodicalId":37937,"journal":{"name":"Contemporary Clinical Trials Communications","volume":"45 ","pages":"Article 101489"},"PeriodicalIF":1.4,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143876715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protocol of Brief Behavioral Treatment for insomnia intervention for adult patients with cancer and their sleep-partner caregivers 成年癌症患者及其睡眠伴侣护理者失眠干预的简短行为治疗方案
IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-04-19 DOI: 10.1016/j.conctc.2025.101486
Youngmee Kim , Thomas C. Tsai , Wendy M. Troxel

Background

Sleep disturbance is common and problematic among both patients with cancer and their sleep-partner caregivers. Although one's sleep affects the partner's sleep, existing psychobehavioral interventions have targeted patients' and caregivers' sleep problems independently.

Methods

We adapt the Brief Behavioral Treatment for Insomnia (BBTI) for both adult patients and their sleep-partner caregivers in the context of cancer. This protocol is to test the feasibility and acceptability as well as to provide preliminary efficacy of the BBTI for Couples with Cancer (BBTI-CC) intervention, which is to reduce sleep disturbance and improving sleep quality of both adults with cancer and their sleep-partner caregivers. The intervention will be delivered weekly for 4 weeks. Questionnaire and daily sleep logs will be collected at baseline (T1) and one-week after conclusion of the intervention (T2). Satisfaction with the intervention will be assessed weekly for 4 weeks.

Results

We estimate 18 dyads will be enrolled (18 patients and 18 caregivers). We expect >75 % of eligible and screened dyads will enroll within the enrollment period, >80 % of enrolled dyads will complete the intervention, and >80 % of participants will report satisfaction across all acceptability measures. We also expect BBTI-CC will reveal a small-to-medium effect on sleep efficiency (primary outcome), overall sleep disturbance, subjective sleep quality, and insomnia severity (secondary outcomes).

Conclusions

Results will inform the feasibility and acceptability of conducting a dyadic sleep behavioral intervention, and provide preliminary efficacy data to guide further refinement of intervention content and procedure for adult patients with cancer and their sleep-partner caregivers.
背景:睡眠障碍在癌症患者和他们的睡眠伴侣照顾者中都是常见的问题。虽然一个人的睡眠会影响伴侣的睡眠,但现有的心理行为干预措施都是针对患者和护理人员的睡眠问题独立进行的。方法将失眠简短行为治疗(BBTI)应用于癌症背景下的成年患者及其睡眠伴侣护理者。本方案旨在检验BBTI for Couples with Cancer (BBTI- cc)干预的可行性和可接受性,并提供初步疗效,以减少成人癌症患者及其睡眠伴侣照顾者的睡眠障碍,提高睡眠质量。干预将每周进行一次,持续4周。在基线(T1)和干预结束后一周(T2)收集问卷和每日睡眠记录。每周一次评估干预的满意度,持续4周。结果我们估计将纳入18对(18名患者和18名护理人员)。我们预计75%的符合条件和筛选的夫妇将在登记期内登记,80%的登记夫妇将完成干预,80%的参与者将报告所有可接受性措施的满意度。我们还预计BBTI-CC将显示出对睡眠效率(主要结果)、整体睡眠障碍、主观睡眠质量和失眠严重程度(次要结果)的中小型影响。结论本研究结果将为开展二元睡眠行为干预的可行性和可接受性提供依据,并为指导成年癌症患者及其睡眠伴护理者进一步完善干预内容和程序提供初步疗效数据。
{"title":"Protocol of Brief Behavioral Treatment for insomnia intervention for adult patients with cancer and their sleep-partner caregivers","authors":"Youngmee Kim ,&nbsp;Thomas C. Tsai ,&nbsp;Wendy M. Troxel","doi":"10.1016/j.conctc.2025.101486","DOIUrl":"10.1016/j.conctc.2025.101486","url":null,"abstract":"<div><h3>Background</h3><div>Sleep disturbance is common and problematic among both patients with cancer and their sleep-partner caregivers. Although one's sleep affects the partner's sleep, existing psychobehavioral interventions have targeted patients' and caregivers' sleep problems independently.</div></div><div><h3>Methods</h3><div>We adapt the Brief Behavioral Treatment for Insomnia (BBTI) for both adult patients and their sleep-partner caregivers in the context of cancer. This protocol is to test the feasibility and acceptability as well as to provide preliminary efficacy of the BBTI for Couples with Cancer (BBTI-CC) intervention, which is to reduce sleep disturbance and improving sleep quality of both adults with cancer and their sleep-partner caregivers. The intervention will be delivered weekly for 4 weeks. Questionnaire and daily sleep logs will be collected at baseline (T1) and one-week after conclusion of the intervention (T2). Satisfaction with the intervention will be assessed weekly for 4 weeks.</div></div><div><h3>Results</h3><div>We estimate 18 dyads will be enrolled (18 patients and 18 caregivers). We expect &gt;75 % of eligible and screened dyads will enroll within the enrollment period, &gt;80 % of enrolled dyads will complete the intervention, and &gt;80 % of participants will report satisfaction across all acceptability measures. We also expect BBTI-CC will reveal a small-to-medium effect on sleep efficiency (primary outcome), overall sleep disturbance, subjective sleep quality, and insomnia severity (secondary outcomes).</div></div><div><h3>Conclusions</h3><div>Results will inform the feasibility and acceptability of conducting a dyadic sleep behavioral intervention, and provide preliminary efficacy data to guide further refinement of intervention content and procedure for adult patients with cancer and their sleep-partner caregivers.</div></div>","PeriodicalId":37937,"journal":{"name":"Contemporary Clinical Trials Communications","volume":"45 ","pages":"Article 101486"},"PeriodicalIF":1.4,"publicationDate":"2025-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143852341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design and refinement of a clinical trial staffing model within the evolving landscape of oncology clinical trials 在肿瘤临床试验不断发展的环境中设计和改进临床试验人员配置模型
IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-04-15 DOI: 10.1016/j.conctc.2025.101485
Ellen Siglinsky, Hannah Phan, Silviya Meletath, Amber Neal, David E. Gerber, Asal Rahimi, Erin L. Williams

Background

Quantifying workload for clinical trial staff represents an ongoing challenge for healthcare facilities conducting cancer clinical trials. We developed and evaluated a staffing model designed to meet this need.

Methods

To address individual protocol acuity, the model's algorithms include metrics to account for visit frequency, and the quantity, and types of research-related procedures. Since implementation in 2012, the model has been used to justify clinical research team resource needs and to establish metrics for leadership to reference when reviewing replacement positions; particularly useful to justify resources at the institutional level during the COVID-19 pandemic.
In recent years, we identified a gap between predicted and actual staff workload. This precipitated a comprehensive review in 2021 of all aspects of scoring within the model including a comparison to modern protocols to ensure accounting for all types of protocol-related procedures and tests.

Results

Further investigation identified increasing complexity of trial screening, which had not been accounted for in the initial model. Specifically, screening-related activities accounted for up to 25% of coordinator effort. We incorporated this work into the model and demonstrated a statistically significant change in average protocol acuity (P = 0.002) following refinement of scoring to include study-specific screening complexity.

Conclusion

Over the past decade, cancer clinical trial screening has increased in complexity and duration. Planning a cancer center's clinical trial workforce requires consideration of screening-related staff effort. For any effort model to be successful, ongoing examination and malleability are critical in this evolving landscape of clinical trials.
对开展癌症临床试验的医疗机构来说,量化临床试验人员的工作量是一项持续的挑战。我们开发并评估了一个人员配置模型,旨在满足这一需求。为了解决个人协议的敏锐性,该模型的算法包括访问频率、数量和研究相关程序类型的指标。自2012年实施以来,该模型已被用于证明临床研究团队的资源需求,并为领导层在审查替代职位时建立参考指标;在2019冠状病毒病大流行期间,这尤其有助于证明机构一级资源的合理性。近年来,我们发现预期工作量与实际工作量之间存在差距。这促成了2021年对该模型内评分的所有方面进行全面审查,包括与现代协议进行比较,以确保考虑到所有类型的协议相关程序和测试。结果进一步的调查发现,试验筛选的复杂性日益增加,这在最初的模型中没有考虑到。具体来说,与筛选相关的活动占协调员工作的25%。我们将这项工作纳入模型,并在细化评分以包括研究特定筛选复杂性后,证明了平均方案敏锐度的统计学显著变化(P = 0.002)。结论在过去的十年中,癌症临床试验筛查的复杂性和持续时间都有所增加。规划癌症中心的临床试验人员需要考虑与筛查相关的工作人员的努力。任何努力模式要取得成功,持续的检查和延展性在这个不断发展的临床试验领域是至关重要的。
{"title":"Design and refinement of a clinical trial staffing model within the evolving landscape of oncology clinical trials","authors":"Ellen Siglinsky,&nbsp;Hannah Phan,&nbsp;Silviya Meletath,&nbsp;Amber Neal,&nbsp;David E. Gerber,&nbsp;Asal Rahimi,&nbsp;Erin L. Williams","doi":"10.1016/j.conctc.2025.101485","DOIUrl":"10.1016/j.conctc.2025.101485","url":null,"abstract":"<div><h3>Background</h3><div>Quantifying workload for clinical trial staff represents an ongoing challenge for healthcare facilities conducting cancer clinical trials. We developed and evaluated a staffing model designed to meet this need.</div></div><div><h3>Methods</h3><div>To address individual protocol acuity, the model's algorithms include metrics to account for visit frequency, and the quantity, and types of research-related procedures. Since implementation in 2012, the model has been used to justify clinical research team resource needs and to establish metrics for leadership to reference when reviewing replacement positions; particularly useful to justify resources at the institutional level during the COVID-19 pandemic.</div><div>In recent years, we identified a gap between predicted and actual staff workload. This precipitated a comprehensive review in 2021 of all aspects of scoring within the model including a comparison to modern protocols to ensure accounting for all types of protocol-related procedures and tests.</div></div><div><h3>Results</h3><div>Further investigation identified increasing complexity of trial screening, which had not been accounted for in the initial model. Specifically, screening-related activities accounted for up to 25% of coordinator effort. We incorporated this work into the model and demonstrated a statistically significant change in average protocol acuity (<em>P</em> = 0.002) following refinement of scoring to include study-specific screening complexity.</div></div><div><h3>Conclusion</h3><div>Over the past decade, cancer clinical trial screening has increased in complexity and duration. Planning a cancer center's clinical trial workforce requires consideration of screening-related staff effort. For any effort model to be successful, ongoing examination and malleability are critical in this evolving landscape of clinical trials.</div></div>","PeriodicalId":37937,"journal":{"name":"Contemporary Clinical Trials Communications","volume":"45 ","pages":"Article 101485"},"PeriodicalIF":1.4,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143870580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study protocol: Apps and peer support for a healthy future and living well with diabetes (APHLID-M) 研究方案:应用程序和同伴支持糖尿病患者的健康未来和生活(APHLID-M)
IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-04-14 DOI: 10.1016/j.conctc.2025.101484
K.O. Mathews , F. MacMillan , V. Wong , M. Craig , J.R. Greenfield , R. Hicks , T. Jones , A. Poynten , T. Wong , M. Reyes , K. Tannous , C. Wilson , P. Hay , S. Abdo , M.K. Piya , J. Lai , M. Venigalla , R. Thomson , D. Simmons

Background

Mental health conditions are common among non-pregnant young people with any form of diabetes, affecting diabetes self-management and increasing complications risk. Limited evidence exists on whether smartphone applications “apps” combining diabetes and mental health (MH) support can improve self-management and MH in these young people. The Apps and Peer support for a Healthy future and Living Well with Diabetes (APHLID-M) multicentre study includes two randomised controlled trials (RCTs) testing such an app, aimed at reducing distress among young adults with diabetes with and without a mental health condition (MHC).

Methods and analysis

An app containing diabetes and MH resources was configured onto a pre-existing, digital health platform. Young adults aged 16–30 years with diabetes will be recruited from eight Australian outpatient clinics, screened using the Kessler Psychological Distress Scale (K10) and the Problem Areas in Diabetes (PAID) questionnaires. Based on MH status, participants will be allocated to the primary RCT (MHC group) or a nested-exploratory RCT (No-MHC group) and randomised by site to the “app” (Intervention) or “no app” (control). All participants will have access to peer support and will continue to receive standard diabetes care through their clinic. Recruitment will end once 142 participants are enrolled in the primary RCT. The primary outcome is change in psychological distress (K10), and the secondary outcome change in HbA1c, assessed at baseline and 6 months.

Discussion

APHLID-M will offer valuable insights into effects of digital technology in enhancing MH (particularly distress) physical health and well-being in young people with diabetes.
心理健康状况在患有任何形式糖尿病的未怀孕青年中都很常见,影响糖尿病的自我管理并增加并发症的风险。关于智能手机应用程序结合糖尿病和心理健康(MH)支持是否能改善这些年轻人的自我管理和MH的证据有限。app和同伴支持健康未来和糖尿病患者生活(aphid - m)多中心研究包括两个随机对照试验(rct)测试这样一个应用程序,旨在减少有或没有精神健康状况(MHC)的年轻糖尿病患者的痛苦。方法和分析一个包含糖尿病和MH资源的应用程序被配置到一个已有的数字健康平台上。年龄在16-30岁的年轻糖尿病患者将从8个澳大利亚门诊诊所招募,使用Kessler心理困扰量表(K10)和糖尿病问题领域(PAID)问卷进行筛选。根据MHC状态,参与者将被分配到主要RCT (MHC组)或嵌套探索性RCT(无MHC组),并按地点随机分配到“应用程序”(干预)或“无应用程序”(对照组)。所有参与者都将获得同伴支持,并将继续通过他们的诊所接受标准的糖尿病治疗。一旦142名参与者被纳入主要随机对照试验,招募将结束。主要结局是心理困扰(K10)的改变,次要结局是糖化血红蛋白(HbA1c)的改变,在基线和6个月时进行评估。讨论aphlid - m将为数字技术在提高年轻糖尿病患者的身体健康和福祉方面的影响提供有价值的见解。
{"title":"Study protocol: Apps and peer support for a healthy future and living well with diabetes (APHLID-M)","authors":"K.O. Mathews ,&nbsp;F. MacMillan ,&nbsp;V. Wong ,&nbsp;M. Craig ,&nbsp;J.R. Greenfield ,&nbsp;R. Hicks ,&nbsp;T. Jones ,&nbsp;A. Poynten ,&nbsp;T. Wong ,&nbsp;M. Reyes ,&nbsp;K. Tannous ,&nbsp;C. Wilson ,&nbsp;P. Hay ,&nbsp;S. Abdo ,&nbsp;M.K. Piya ,&nbsp;J. Lai ,&nbsp;M. Venigalla ,&nbsp;R. Thomson ,&nbsp;D. Simmons","doi":"10.1016/j.conctc.2025.101484","DOIUrl":"10.1016/j.conctc.2025.101484","url":null,"abstract":"<div><h3>Background</h3><div>Mental health conditions are common among non-pregnant young people with any form of diabetes, affecting diabetes self-management and increasing complications risk. Limited evidence exists on whether smartphone applications “apps” combining diabetes and mental health (MH) support can improve self-management and MH in these young people. The Apps and Peer support for a Healthy future and Living Well with Diabetes (APHLID-M) multicentre study includes two randomised controlled trials (RCTs) testing such an app, aimed at reducing distress among young adults with diabetes with and without a mental health condition (MHC).</div></div><div><h3>Methods and analysis</h3><div>An app containing diabetes and MH resources was configured onto a pre-existing, digital health platform. Young adults aged 16–30 years with diabetes will be recruited from eight Australian outpatient clinics, screened using the Kessler Psychological Distress Scale (K10) and the Problem Areas in Diabetes (PAID) questionnaires. Based on MH status, participants will be allocated to the primary RCT (MHC group) or a nested-exploratory RCT (No-MHC group) and randomised by site to the “app” (Intervention) or “no app” (control). All participants will have access to peer support and will continue to receive standard diabetes care through their clinic. Recruitment will end once 142 participants are enrolled in the primary RCT. The primary outcome is change in psychological distress (K10), and the secondary outcome change in HbA1c, assessed at baseline and 6 months.</div></div><div><h3>Discussion</h3><div>APHLID-M will offer valuable insights into effects of digital technology in enhancing MH (particularly distress) physical health and well-being in young people with diabetes.</div></div>","PeriodicalId":37937,"journal":{"name":"Contemporary Clinical Trials Communications","volume":"45 ","pages":"Article 101484"},"PeriodicalIF":1.4,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143852342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel approaches to recruiting clinical sites for embedded pragmatic clinical trials: Insights from the AIM-back trial 为嵌入式实用临床试验招募临床研究机构的新方法:AIM-back 试验的启示
IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-04-11 DOI: 10.1016/j.conctc.2025.101483
Tyler L. Cope , Steven Z. George , S. Nicole Hastings , Courtni France , Christa Tumminello , Cynthia J. Coffman , Ashley Choate , Trevor A. Lentz

Background

Embedded pragmatic clinical trials (ePCTs) assess interventions in real-world settings. Best practices for recruiting clinical sites for ePCTs are unknown, especially for sites that aren't known to the study team or familiar with clinical research. We describe the site recruitment process for AIM-Back, an ePCT of two nonpharmacologic pathways for low back pain within the Veterans Health Administration (VA).

Methods

During the planning phase of the AIM-Back trial, we aimed to recruit 18–20 sites. Eligible sites required provider capacity, administrative support, and geographic separation to avoid contamination. Our three-step approach involved: (1) lead (VA personnel) identification through existing VA contacts, data repositories of VA clinicians, and promotional outreach at events and listservs; (2) lead engagement via tailored communications emphasizing participation benefits; and (3) virtual meetings with administrators and clinicians.

Results

We identified 184 leads across 53 VA healthcare systems. Leads from 40 systems responded to outreach, and recruitment meetings were conducted with 23 systems involving primary care, physical therapy, research staff, and leadership. We met our recruitment goal, securing participation agreements from 19 sites, with a median timeline from outreach to participation agreement of 3.7 months. Common reasons for non-participation included infrastructure and resource constraints, resistance to new clinical programs, and competing programs.

Conclusion

AIM-Back's recruitment highlights ePCT site recruitment complexities for trials engaging new clinical research sites. Our innovative three-step recruitment approach provides an example for similarly designed trials. Future ePCTs should consider comprehensive recruitment strategies to ensure clinician buy-in, study feasibility, and broaden existing networks for completing ePCTs.
嵌入式实用临床试验(epct)评估现实世界环境中的干预措施。为epct招募临床地点的最佳实践尚不清楚,特别是对于研究团队不知道或不熟悉临床研究的地点。我们描述了AIM-Back的部位招募过程,这是退伍军人健康管理局(VA)治疗腰痛的两种非药物途径的ePCT。方法在AIM-Back试验的计划阶段,我们的目标是招募18-20个站点。符合条件的站点需要供应商能力、管理支持和地理隔离以避免污染。我们的三步方法包括:(1)通过现有的VA联系人,VA临床医生的数据库,以及在活动和列表服务器上的推广外展来识别(VA人员);(2)通过强调参与利益的量身定制的沟通引导参与;(3)与管理人员和临床医生的虚拟会议。结果我们在53个VA医疗保健系统中确定了184条线索。来自40个系统的领导对外联活动作出了回应,并与23个系统进行了招聘会议,涉及初级保健、物理治疗、研究人员和领导。我们实现了招聘目标,从19个网站获得了参与协议,从外联到参与协议的中间时间为3.7个月。不参与的常见原因包括基础设施和资源限制,对新的临床项目的抵制,以及竞争性项目。结论aim - back的招募突出了ePCT地点招募的复杂性,以参与新的临床研究地点。我们创新的三步招募方法为类似设计的试验提供了一个范例。未来的epct应考虑全面的招聘策略,以确保临床医生的购买,研究的可行性,并扩大现有的网络,以完成epct。
{"title":"Novel approaches to recruiting clinical sites for embedded pragmatic clinical trials: Insights from the AIM-back trial","authors":"Tyler L. Cope ,&nbsp;Steven Z. George ,&nbsp;S. Nicole Hastings ,&nbsp;Courtni France ,&nbsp;Christa Tumminello ,&nbsp;Cynthia J. Coffman ,&nbsp;Ashley Choate ,&nbsp;Trevor A. Lentz","doi":"10.1016/j.conctc.2025.101483","DOIUrl":"10.1016/j.conctc.2025.101483","url":null,"abstract":"<div><h3>Background</h3><div>Embedded pragmatic clinical trials (ePCTs) assess interventions in real-world settings. Best practices for recruiting clinical sites for ePCTs are unknown, especially for sites that aren't known to the study team or familiar with clinical research. We describe the site recruitment process for AIM-Back, an ePCT of two nonpharmacologic pathways for low back pain within the Veterans Health Administration (VA).</div></div><div><h3>Methods</h3><div>During the planning phase of the AIM-Back trial, we aimed to recruit 18–20 sites. Eligible sites required provider capacity, administrative support, and geographic separation to avoid contamination. Our three-step approach involved: (1) lead (VA personnel) identification through existing VA contacts, data repositories of VA clinicians, and promotional outreach at events and listservs; (2) lead engagement via tailored communications emphasizing participation benefits; and (3) virtual meetings with administrators and clinicians.</div></div><div><h3>Results</h3><div>We identified 184 leads across 53 VA healthcare systems. Leads from 40 systems responded to outreach, and recruitment meetings were conducted with 23 systems involving primary care, physical therapy, research staff, and leadership. We met our recruitment goal, securing participation agreements from 19 sites, with a median timeline from outreach to participation agreement of 3.7 months. Common reasons for non-participation included infrastructure and resource constraints, resistance to new clinical programs, and competing programs.</div></div><div><h3>Conclusion</h3><div>AIM-Back's recruitment highlights ePCT site recruitment complexities for trials engaging new clinical research sites. Our innovative three-step recruitment approach provides an example for similarly designed trials. Future ePCTs should consider comprehensive recruitment strategies to ensure clinician buy-in, study feasibility, and broaden existing networks for completing ePCTs.</div></div>","PeriodicalId":37937,"journal":{"name":"Contemporary Clinical Trials Communications","volume":"45 ","pages":"Article 101483"},"PeriodicalIF":1.4,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143859283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined chiropractic care and Tai Chi for chronic neck pain: A protocol for a pilot randomized trial 脊椎指压疗法和太极拳联合治疗慢性颈部疼痛:一项随机试验方案
IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-04-11 DOI: 10.1016/j.conctc.2025.101482
Peter M. Wayne , Robert Vining , Cynthia R. Long , Wren M. Burton , Daniel Litrownik , Jacqueline Guzman , Karen Kilgore , Thomas J. Hagan , Pamela M. Rist , Matthew H. Kowalski

Background

Neck pain presents a personal and socioeconomic burden globally. Despite increasing prevalence, research on chronic neck pain (CNP) is limited and management relies on generalized approaches. There is growing interest in non-pharmacological interventions, however their efficacy remains uncertain due to the multifactorial etiology of CNP. Two interventions, multimodal chiropractic care (MCC) and Tai Chi, have shown promise individually in managing CNP, and when combined may offer synergistic benefits. This pilot study aims to assess the feasibility of combining these interventions for CNP.
Methods/design: Forty-eight adults, aged 18-65y, with CNP defined as occurring ≥5 days a week for ≥3 consecutive months, severity of ≥3 on the numeric rating scale, and a score of ≥5 on the Neck Disability Index will be recruited. Participants will be randomized 1:1:1 to one of the three treatment groups (MCC plus Tai Chi and Enhanced Usual Care (EUC), MCC plus EUC, or EUC alone). The MCC was validated using a modified Delphi approach. Primary outcomes relate to feasibility (recruitment, retention, and adherence) and secondary outcomes include clinical measures of neck pain severity and disability, health-related quality-of-life, psychosocial well-being, and physical function. Outcomes will be assessed at baseline, 16-weeks (post-intervention), and 24-weeks. Qualitative interviews will be conducted.

Discussion

Results of this study will provide preliminary evidence regarding the feasibility and clinical evaluation of pragmatically delivered MCC, alone or in combination with Tai Chi, for individuals with CNP. These data will be used to inform the design of a fully powered, factorial trial evaluating two promising non-pharmacological therapies for CNP.

Trial registration

This study is registered in ClinicalTrials.gov (NCT05726331).
颈痛是全球范围内的个人和社会经济负担。尽管越来越普遍,慢性颈部疼痛(CNP)的研究是有限的,管理依赖于广义的方法。人们对非药物干预越来越感兴趣,但由于CNP的多因素病因,其疗效仍不确定。两种干预措施,多模式脊椎指压治疗(MCC)和太极,在单独治疗CNP方面显示出希望,当联合使用时可能会产生协同效益。这项试点研究旨在评估将这些干预措施结合起来治疗CNP的可行性。方法/设计:招募48名成年人,年龄18-65岁,CNP定义为每周发生≥5天,连续≥3个月,数字评定量表严重程度≥3,颈部残疾指数得分≥5。参与者将以1:1:1的比例随机分配到三个治疗组(MCC +太极和强化常规护理(EUC), MCC + EUC或单独EUC)中的一个。采用改进的德尔菲法对MCC进行验证。主要结局与可行性有关(招募、保留和坚持),次要结局包括颈部疼痛严重程度和残疾、健康相关生活质量、社会心理健康和身体功能的临床测量。结果将在基线、16周(干预后)和24周进行评估。将进行定性访谈。本研究的结果将为实际提供MCC的可行性和临床评估提供初步证据,单独或联合太极,用于CNP患者。这些数据将用于设计一项全动力、析因试验,评估两种有希望的CNP非药物治疗方法。试验注册本研究已在ClinicalTrials.gov注册(NCT05726331)。
{"title":"Combined chiropractic care and Tai Chi for chronic neck pain: A protocol for a pilot randomized trial","authors":"Peter M. Wayne ,&nbsp;Robert Vining ,&nbsp;Cynthia R. Long ,&nbsp;Wren M. Burton ,&nbsp;Daniel Litrownik ,&nbsp;Jacqueline Guzman ,&nbsp;Karen Kilgore ,&nbsp;Thomas J. Hagan ,&nbsp;Pamela M. Rist ,&nbsp;Matthew H. Kowalski","doi":"10.1016/j.conctc.2025.101482","DOIUrl":"10.1016/j.conctc.2025.101482","url":null,"abstract":"<div><h3>Background</h3><div>Neck pain presents a personal and socioeconomic burden globally. Despite increasing prevalence, research on chronic neck pain (CNP) is limited and management relies on generalized approaches. There is growing interest in non-pharmacological interventions, however their efficacy remains uncertain due to the multifactorial etiology of CNP. Two interventions, multimodal chiropractic care (MCC) and Tai Chi, have shown promise individually in managing CNP, and when combined may offer synergistic benefits. This pilot study aims to assess the feasibility of combining these interventions for CNP.</div><div>Methods/design: Forty-eight adults, aged 18-65y, with CNP defined as occurring ≥5 days a week for ≥3 consecutive months, severity of ≥3 on the numeric rating scale, and a score of ≥5 on the Neck Disability Index will be recruited. Participants will be randomized 1:1:1 to one of the three treatment groups (MCC plus Tai Chi and Enhanced Usual Care (EUC), MCC plus EUC, or EUC alone). The MCC was validated using a modified Delphi approach. Primary outcomes relate to feasibility (recruitment, retention, and adherence) and secondary outcomes include clinical measures of neck pain severity and disability, health-related quality-of-life, psychosocial well-being, and physical function. Outcomes will be assessed at baseline, 16-weeks (post-intervention), and 24-weeks. Qualitative interviews will be conducted.</div></div><div><h3>Discussion</h3><div>Results of this study will provide preliminary evidence regarding the feasibility and clinical evaluation of pragmatically delivered MCC, alone or in combination with Tai Chi, for individuals with CNP. These data will be used to inform the design of a fully powered, factorial trial evaluating two promising non-pharmacological therapies for CNP.</div></div><div><h3>Trial registration</h3><div>This study is registered in <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> (NCT05726331).</div></div>","PeriodicalId":37937,"journal":{"name":"Contemporary Clinical Trials Communications","volume":"45 ","pages":"Article 101482"},"PeriodicalIF":1.4,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143859297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Training to Move an Evidence-based Dementia Caregiver Support Program into Practice: A pragmatic, randomized, non-inferiority trial protocol 将以证据为基础的痴呆症护理人员支持计划付诸实践的培训:一项实用的、随机的、非劣效性的试验方案
IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-04-05 DOI: 10.1016/j.conctc.2025.101478
Nancy A. Hodgson , Miranda V. McPhillips , Karen B. Hirschman , Emily Summerhayes , Catherine Verrier Piersol , Laura N. Gitlin

Background

Despite over 200 evidence-based dementia caregiver programs, we know little about the best approaches for optimally scaling these programs in daily service contexts, nor do we fully understand the most effective approaches of ensuring successful implementation. As a result, a small fraction of the many individuals living with dementia and their caregivers within in the US have access to evidence-based programs. A leading barrier to implementation of evidence-based dementia caregiver support programs into long-term care settings is the lack of streamlined, scalable, user-friendly, and tested training modalities.

Objective

To describe the protocol for a study evaluating the implementation of the Care of Persons in their Environment (COPE) in Programs of All-Inclusive Care for the Elderly (PACE) setting. The COPE in PACE study aims to determine if self-paced, online training in the evidence-based dementia care program COPE is non-inferior to the traditional, in-person, instructor-led training for improving clinician knowledge and competence, patient symptoms, function, caregiver confidence and burden, and therapeutic alliance between clinicians and caregivers.
Methods/Design: Pragmatic, multisite randomized controlled non-inferiority trial is being used to assess the implementation of COPE into PACE. The study utilizes a type III hybrid effectiveness design with a primary focus on measuring implementation factors and a secondary focus on measuring COPE effectiveness through caregiver and patient outcomes and therapeutic alliance. The ‘COPE in PACE’ study is an ongoing trial being conducted in 10 PACE settings throughout the US (NCT04165213).

Discussion

This study design has potential to guide future translational efforts by providing program adaptation, fidelity monitoring and implementation details to enhance scalability of evidence-based programs.

Clinical trial registration

NCT04165213.
尽管有200多个基于证据的痴呆症护理项目,但我们对在日常服务环境中优化这些项目的最佳方法知之甚少,我们也不完全了解确保成功实施的最有效方法。因此,在美国的许多痴呆症患者及其护理人员中,只有一小部分人能够获得基于证据的项目。在长期护理环境中实施以证据为基础的痴呆症护理人员支持规划的主要障碍是缺乏精简、可扩展、用户友好和经过测试的培训模式。目的描述一项评估老年人全包照护计划(PACE)实施环境中人照护(COPE)的研究方案。PACE中的COPE研究旨在确定基于证据的痴呆护理项目COPE中自定进度的在线培训是否优于传统的、面对面的、有指导的培训,以提高临床医生的知识和能力、患者的症状、功能、护理人员的信心和负担,以及临床医生和护理人员之间的治疗联盟。方法/设计:采用实用的多地点随机对照非劣效性试验来评估COPE在PACE中的实施情况。该研究采用III型混合有效性设计,主要侧重于测量实施因素,其次侧重于通过护理者和患者的结果以及治疗联盟来测量COPE的有效性。“COPE in PACE”研究是一项正在美国10个PACE机构进行的正在进行的试验(NCT04165213)。本研究设计有可能通过提供项目适应性、保真度监测和实施细节来指导未来的转化工作,以增强循证项目的可扩展性。临床试验注册号:nct04165213。
{"title":"Training to Move an Evidence-based Dementia Caregiver Support Program into Practice: A pragmatic, randomized, non-inferiority trial protocol","authors":"Nancy A. Hodgson ,&nbsp;Miranda V. McPhillips ,&nbsp;Karen B. Hirschman ,&nbsp;Emily Summerhayes ,&nbsp;Catherine Verrier Piersol ,&nbsp;Laura N. Gitlin","doi":"10.1016/j.conctc.2025.101478","DOIUrl":"10.1016/j.conctc.2025.101478","url":null,"abstract":"<div><h3>Background</h3><div>Despite over 200 evidence-based dementia caregiver programs, we know little about the best approaches for optimally scaling these programs in daily service contexts, nor do we fully understand the most effective approaches of ensuring successful implementation. As a result, a small fraction of the many individuals living with dementia and their caregivers within in the US have access to evidence-based programs. A leading barrier to implementation of evidence-based dementia caregiver support programs into long-term care settings is the lack of streamlined, scalable, user-friendly, and tested training modalities.</div></div><div><h3>Objective</h3><div>To describe the protocol for a study evaluating the implementation of the Care of Persons in their Environment (COPE) in Programs of All-Inclusive Care for the Elderly (PACE) setting. The COPE in PACE study aims to determine if self-paced, online training in the evidence-based dementia care program COPE is non-inferior to the traditional, in-person, instructor-led training for improving clinician knowledge and competence, patient symptoms, function, caregiver confidence and burden, and therapeutic alliance between clinicians and caregivers.</div><div>Methods/Design: Pragmatic, multisite randomized controlled non-inferiority trial is being used to assess the implementation of COPE into PACE. The study utilizes a type III hybrid effectiveness design with a primary focus on measuring implementation factors and a secondary focus on measuring COPE effectiveness through caregiver and patient outcomes and therapeutic alliance. The ‘COPE in PACE’ study is an ongoing trial being conducted in 10 PACE settings throughout the US (NCT04165213).</div></div><div><h3>Discussion</h3><div>This study design has potential to guide future translational efforts by providing program adaptation, fidelity monitoring and implementation details to enhance scalability of evidence-based programs.</div></div><div><h3>Clinical trial registration</h3><div>NCT04165213.</div></div>","PeriodicalId":37937,"journal":{"name":"Contemporary Clinical Trials Communications","volume":"45 ","pages":"Article 101478"},"PeriodicalIF":1.4,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143791769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A mixed-methods study on the recruitment of patients from ethnic minority groups to clinical trials in a central London teaching hospital 伦敦中心教学医院临床试验招募少数民族患者的混合方法研究
IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-04-01 DOI: 10.1016/j.conctc.2025.101475
Cecilia Vindrola-Padros , Katie Gilchrist , Stuart Braverman , Rumana Omar , Edward Merivale , Ambar Hussenbux , Sanjay Khanna , Patience Renias-Zuva , Nick McNally , Rosamund Yu

Background/aims

Additional research is needed to fully understand barriers in recruitment to clinical trials and how these might affect different ethnic groups. The aim of this study was to explore the factors acting as barriers and facilitators in the process of recruiting patients to clinical trials in a UK (central London) teaching hospital, with a particular focus on patients from ethnic minority groups, and on areas where action could be taken.

Methods

The study was designed as a mixed-methods study comprised of: 1) a quantitative workstream which explored variations in the ethnic and gender breakdown of people admitted to hospital relative to the demographic characteristics of patients enrolled into research studies at the hospital, and 2) a qualitative workstream which explored staff experiences of recruiting patients to clinical trials and patients’ experiences of being approached to take part in a clinical trial. The quantitative workstream provided the necessary context for the design of the qualitative workstream.

Results

We found that the chances of being involved in research at the hospital were lower in all ethnic minority groups and lower amongst female patients. Some of the factors acting as barriers in trial participation included patients’ perceptions of clinical research as a form of experimental medicine that might have high risks, the role of family members in decision-making processes, and language barriers (where patients might not be fluent in English and the study information is not communicated in other languages). Potential strategies to address underrepresentation included the development of accessible information about research and how patient data are used, development of study materials in multiple languages and use of interpreters during the recruitment process, support for staff in involving family members in decision-making and a greater ethnic diversity within study teams.

Conclusions

The under-representation of people from minority ethnic populations in clinical research remains a major challenge, impacting on the rigour and applicability of findings as well as implying some populations are missing out on the benefits of research. Study design needs to place greater emphasis on patient need and convenience and therefore to take greater account of the deterrent effect of financial and time burdens on trial participants. Recruiting sites and sponsors need to review the provision of interpreting and translation support for trials, including availability and cost to individual studies and staff confidence in reliability.
背景/目的需要进一步的研究来充分了解临床试验招募的障碍以及这些障碍如何影响不同的种族群体。本研究的目的是探索在英国(伦敦市中心)教学医院招募患者进行临床试验的过程中作为障碍和促进因素的因素,特别关注少数民族患者,以及可以采取行动的领域。方法本研究设计为混合方法研究,包括:1)定量工作流程,探讨住院患者的种族和性别分类相对于在医院参加研究的患者的人口统计学特征的变化;2)定性工作流程,探讨工作人员招募患者参加临床试验的经历和患者被接触参加临床试验的经历。定量工作流程为定性工作流程的设计提供了必要的环境。结果我们发现,所有少数民族患者参与医院研究的机会都较低,女性患者的机会更低。参与试验的一些障碍因素包括患者认为临床研究是一种可能具有高风险的实验医学形式,家庭成员在决策过程中的作用,以及语言障碍(患者可能英语不流利,研究信息没有用其他语言交流)。解决代表性不足问题的潜在战略包括开发有关研究和如何使用患者数据的无障碍信息,开发多种语言的研究材料,在招聘过程中使用口译员,支持工作人员让家庭成员参与决策,以及在研究团队中增加种族多样性。结论:少数民族人群在临床研究中的代表性不足仍然是一个主要挑战,影响了研究结果的严谨性和适用性,也意味着一些人群错过了研究的好处。研究设计需要更加强调患者的需求和便利性,因此需要更多地考虑经济和时间负担对试验参与者的威慑作用。招募地点和赞助者需要审查为试验提供的口译和笔译支持,包括个别研究的可得性和费用以及工作人员对可靠性的信心。
{"title":"A mixed-methods study on the recruitment of patients from ethnic minority groups to clinical trials in a central London teaching hospital","authors":"Cecilia Vindrola-Padros ,&nbsp;Katie Gilchrist ,&nbsp;Stuart Braverman ,&nbsp;Rumana Omar ,&nbsp;Edward Merivale ,&nbsp;Ambar Hussenbux ,&nbsp;Sanjay Khanna ,&nbsp;Patience Renias-Zuva ,&nbsp;Nick McNally ,&nbsp;Rosamund Yu","doi":"10.1016/j.conctc.2025.101475","DOIUrl":"10.1016/j.conctc.2025.101475","url":null,"abstract":"<div><h3>Background/aims</h3><div>Additional research is needed to fully understand barriers in recruitment to clinical trials and how these might affect different ethnic groups. The aim of this study was to explore the factors acting as barriers and facilitators in the process of recruiting patients to clinical trials in a UK (central London) teaching hospital, with a particular focus on patients from ethnic minority groups, and on areas where action could be taken.</div></div><div><h3>Methods</h3><div>The study was designed as a mixed-methods study comprised of: 1) a quantitative workstream which explored variations in the ethnic and gender breakdown of people admitted to hospital relative to the demographic characteristics of patients enrolled into research studies at the hospital, and 2) a qualitative workstream which explored staff experiences of recruiting patients to clinical trials and patients’ experiences of being approached to take part in a clinical trial. The quantitative workstream provided the necessary context for the design of the qualitative workstream.</div></div><div><h3>Results</h3><div>We found that the chances of being involved in research at the hospital were lower in all ethnic minority groups and lower amongst female patients. Some of the factors acting as barriers in trial participation included patients’ perceptions of clinical research as a form of experimental medicine that might have high risks, the role of family members in decision-making processes, and language barriers (where patients might not be fluent in English and the study information is not communicated in other languages). Potential strategies to address underrepresentation included the development of accessible information about research and how patient data are used, development of study materials in multiple languages and use of interpreters during the recruitment process, support for staff in involving family members in decision-making and a greater ethnic diversity within study teams.</div></div><div><h3>Conclusions</h3><div>The under-representation of people from minority ethnic populations in clinical research remains a major challenge, impacting on the rigour and applicability of findings as well as implying some populations are missing out on the benefits of research. Study design needs to place greater emphasis on patient need and convenience and therefore to take greater account of the deterrent effect of financial and time burdens on trial participants. Recruiting sites and sponsors need to review the provision of interpreting and translation support for trials, including availability and cost to individual studies and staff confidence in reliability.</div></div>","PeriodicalId":37937,"journal":{"name":"Contemporary Clinical Trials Communications","volume":"45 ","pages":"Article 101475"},"PeriodicalIF":1.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143767592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing challenges and barriers to rural Veteran participation in clinical research within the Veterans Affairs healthcare system 解决退伍军人事务医疗保健系统中农村退伍军人参与临床研究的挑战和障碍
IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-04-01 DOI: 10.1016/j.conctc.2025.101466
Marcus R. Johnson , Aliya Asghar , Danielle J. Beck , Tassos Kyriakides , Matthew P. Vincenti , Grant D. Huang
The execution of clinical research in medical facilities that serve rural populations and/or that have lower care complexity levels has been proven to be challenging, as compared to larger healthcare institutions with higher complexity levels. Issues such as isolation, lack of organizational support and resources, difficulty with enrollment of study participants in rural settings, and challenges with identifying and retaining experienced clinical research staff serve as barriers to developing and establishing the necessary infrastructure to conduct clinical research at rural and/or smaller medical facilities. The United States (U.S.) Department of Veterans Affairs’ (VA) has the largest integrated health care system in the country and provides care to over 9 million Veterans. These considerations, combined with feedback collected from a subset of these types of (VA) Medical Centers (VAMCs) on this topic, demonstrate the need for a comprehensive enterprise-level strategy to address these challenges within the VA healthcare system. The VA Cooperative Studies Program (CSP) is a clinical research infrastructure that has vast expertise in the conduct of multi-site clinical research within the VA and is well poised to lead this effort.
This manuscript describes the CSP “Advancing Capacity for Clinical Research through Engagement with Strategic Sites (ACCESS)” initiative. It focuses specifically on the successes, challenges, and lessons learned from the CSP ACCESS Workgroup (AW) during the development and implementation of a comprehensive pilot plan for engaging rural/lower complexity VAMCs (strategic sites) to participate in CSP clinical research.
事实证明,与复杂性较高的大型医疗机构相比,在为农村人口服务和/或护理复杂性较低的医疗机构开展临床研究具有挑战性。隔离、缺乏组织支持和资源、在农村地区招收研究参与者的困难以及在确定和留住有经验的临床研究人员方面遇到的挑战等问题,阻碍了发展和建立必要的基础设施,以便在农村和/或较小的医疗机构开展临床研究。美国(U.S.)退伍军人事务部(VA)拥有全国最大的综合医疗保健系统,为900多万退伍军人提供医疗服务。这些考虑,结合从这些类型(VA)医疗中心(vamc)的一个子集收集的关于此主题的反馈,表明需要一个全面的企业级战略来解决VA医疗保健系统中的这些挑战。退伍军人事务部合作研究项目(CSP)是一个临床研究基础设施,在退伍军人事务部开展多地点临床研究方面拥有丰富的专业知识,并已做好领导这一努力的准备。这份手稿描述了CSP“通过参与战略站点(ACCESS)提高临床研究能力”的倡议。它特别侧重于CSP访问工作组(AW)在制定和实施一项让农村/低复杂性VAMCs(战略站点)参与CSP临床研究的综合试点计划期间的成功、挑战和经验教训。
{"title":"Addressing challenges and barriers to rural Veteran participation in clinical research within the Veterans Affairs healthcare system","authors":"Marcus R. Johnson ,&nbsp;Aliya Asghar ,&nbsp;Danielle J. Beck ,&nbsp;Tassos Kyriakides ,&nbsp;Matthew P. Vincenti ,&nbsp;Grant D. Huang","doi":"10.1016/j.conctc.2025.101466","DOIUrl":"10.1016/j.conctc.2025.101466","url":null,"abstract":"<div><div>The execution of clinical research in medical facilities that serve rural populations and/or that have lower care complexity levels has been proven to be challenging, as compared to larger healthcare institutions with higher complexity levels. Issues such as isolation, lack of organizational support and resources, difficulty with enrollment of study participants in rural settings, and challenges with identifying and retaining experienced clinical research staff serve as barriers to developing and establishing the necessary infrastructure to conduct clinical research at rural and/or smaller medical facilities. The United States (U.S.) Department of Veterans Affairs’ (VA) has the largest integrated health care system in the country and provides care to over 9 million Veterans. These considerations, combined with feedback collected from a subset of these types of (VA) Medical Centers (VAMCs) on this topic, demonstrate the need for a comprehensive enterprise-level strategy to address these challenges within the VA healthcare system. The VA Cooperative Studies Program (CSP) is a clinical research infrastructure that has vast expertise in the conduct of multi-site clinical research within the VA and is well poised to lead this effort.</div><div>This manuscript describes the CSP “Advancing Capacity for Clinical Research through Engagement with Strategic Sites (ACCESS)” initiative. It focuses specifically on the successes, challenges, and lessons learned from the CSP ACCESS Workgroup (AW) during the development and implementation of a comprehensive pilot plan for engaging rural/lower complexity VAMCs (strategic sites) to participate in CSP clinical research.</div></div>","PeriodicalId":37937,"journal":{"name":"Contemporary Clinical Trials Communications","volume":"45 ","pages":"Article 101466"},"PeriodicalIF":1.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143777437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting clinical trial duration via statistical and machine learning models 通过统计和机器学习模型预测临床试验持续时间
IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-03-31 DOI: 10.1016/j.conctc.2025.101473
Joonhyuk Cho , Qingyang Xu , Chi Heem Wong , Andrew W. Lo
We apply survival analysis as well as machine learning models to predict the duration of clinical trials using the largest dataset so far constructed in this domain. Neural network-based DeepSurv yields the most accurate predictions and we identify key factors that are most predictive of trial duration. This methodology may help clinical researchers optimize trial designs for expedited testing, and can also reduce the financial risk of drug development, which in turn will lower the cost of funding and increase the amount of capital allocated to this sector.
我们应用生存分析和机器学习模型来预测临床试验的持续时间,使用迄今为止在该领域构建的最大数据集。基于神经网络的DeepSurv产生最准确的预测,我们确定了最能预测试验持续时间的关键因素。这种方法可以帮助临床研究人员优化试验设计以加快测试,还可以降低药物开发的财务风险,从而降低资助成本并增加分配给该部门的资金数额。
{"title":"Predicting clinical trial duration via statistical and machine learning models","authors":"Joonhyuk Cho ,&nbsp;Qingyang Xu ,&nbsp;Chi Heem Wong ,&nbsp;Andrew W. Lo","doi":"10.1016/j.conctc.2025.101473","DOIUrl":"10.1016/j.conctc.2025.101473","url":null,"abstract":"<div><div>We apply survival analysis as well as machine learning models to predict the duration of clinical trials using the largest dataset so far constructed in this domain. Neural network-based DeepSurv yields the most accurate predictions and we identify key factors that are most predictive of trial duration. This methodology may help clinical researchers optimize trial designs for expedited testing, and can also reduce the financial risk of drug development, which in turn will lower the cost of funding and increase the amount of capital allocated to this sector.</div></div>","PeriodicalId":37937,"journal":{"name":"Contemporary Clinical Trials Communications","volume":"45 ","pages":"Article 101473"},"PeriodicalIF":1.4,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143791768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Contemporary Clinical Trials Communications
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1